SG11202110355RA - Therapeutic microvesicles of probiotic bacteria - Google Patents
Therapeutic microvesicles of probiotic bacteriaInfo
- Publication number
- SG11202110355RA SG11202110355RA SG11202110355RA SG11202110355RA SG11202110355RA SG 11202110355R A SG11202110355R A SG 11202110355RA SG 11202110355R A SG11202110355R A SG 11202110355RA SG 11202110355R A SG11202110355R A SG 11202110355RA SG 11202110355R A SG11202110355R A SG 11202110355RA
- Authority
- SG
- Singapore
- Prior art keywords
- probiotic bacteria
- therapeutic microvesicles
- microvesicles
- therapeutic
- probiotic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1950483 | 2019-04-17 | ||
| SE1951222 | 2019-10-25 | ||
| PCT/SE2020/050397 WO2020214083A1 (en) | 2019-04-17 | 2020-04-17 | Therapeutic microvesicles of probiotic bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202110355RA true SG11202110355RA (en) | 2021-11-29 |
Family
ID=70476308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202110355RA SG11202110355RA (en) | 2019-04-17 | 2020-04-17 | Therapeutic microvesicles of probiotic bacteria |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11857582B2 (en) |
| EP (2) | EP4410298A2 (en) |
| JP (1) | JP7556881B2 (en) |
| KR (1) | KR20220007609A (en) |
| CN (1) | CN113747908A (en) |
| AU (1) | AU2020258788B2 (en) |
| BR (1) | BR112021019663A2 (en) |
| CA (1) | CA3136978A1 (en) |
| CL (1) | CL2021002527A1 (en) |
| EC (1) | ECSP21082738A (en) |
| IL (1) | IL287226A (en) |
| MX (1) | MX2021012631A (en) |
| PL (1) | PL3773648T3 (en) |
| SG (1) | SG11202110355RA (en) |
| WO (1) | WO2020214083A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7556881B2 (en) | 2019-04-17 | 2024-09-26 | バイオガイア エイビー | Therapeutic microvesicles of probiotic bacteria |
| WO2022139530A1 (en) * | 2020-12-23 | 2022-06-30 | 주식회사 리스큐어바이오사이언시스 | Composition for alleviating, preventing or treating autoimmune diseases, comprising lactobacillus sakei-derived extracellular vesicles as active ingredient |
| CN113122478B (en) * | 2021-04-26 | 2022-09-06 | 江南大学 | Lactobacillus paracasei capable of relieving gastrointestinal injury caused by capsaicin and application thereof |
| CN114292801A (en) * | 2021-11-22 | 2022-04-08 | 龚志术 | Domestication method of probiotic strains, Fumi emulsion and preparation method thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3716938A1 (en) * | 1986-05-23 | 1987-11-26 | Heise Dieter | Pharmaceutical composition for the treatment of colic in infants |
| US7374924B2 (en) | 2006-06-05 | 2008-05-20 | Biogaia Ab | Use of selected lactic acid bacteria for reducing infantile colic |
| US8617537B2 (en) | 2008-06-10 | 2013-12-31 | Biogaia Ab | Controlled activation of the reuterin-production machinery of lactobacillus |
| CN103079592B (en) * | 2010-07-01 | 2015-10-21 | 浦项工科大学校产学协力团 | Use from the microbubble treatment of cell and the method for cancer diagnosis |
| JP6858406B2 (en) | 2015-07-27 | 2021-04-14 | セティ株式会社 | Lactic acid bacteria composition, fermented milk and its production method, and fermented milk production kit |
| KR102394638B1 (en) | 2015-09-30 | 2022-05-09 | (주)아모레퍼시픽 | Composition comprising lactic acid bacteria derived extracellular vesicles for preventing hair loss or promoting hair growth |
| MX2019013143A (en) * | 2017-05-05 | 2020-07-14 | Nestle Sa | Treatment of infant colic. |
| KR101853603B1 (en) | 2017-05-18 | 2018-05-02 | 주식회사 쎌바이오텍 | Composition containing of probiotics for using alcohol or acetaldehyde dehydrogenase activity |
| US12059442B2 (en) | 2018-03-29 | 2024-08-13 | Morinaga Milk Industry Co., Ltd. | Obesity treatment using probiotics, composition for reducing body fat, and composition for reducing waist circumference |
| JP7556881B2 (en) | 2019-04-17 | 2024-09-26 | バイオガイア エイビー | Therapeutic microvesicles of probiotic bacteria |
-
2020
- 2020-04-17 JP JP2021561738A patent/JP7556881B2/en active Active
- 2020-04-17 US US17/045,315 patent/US11857582B2/en active Active
- 2020-04-17 SG SG11202110355RA patent/SG11202110355RA/en unknown
- 2020-04-17 EP EP24182877.1A patent/EP4410298A2/en active Pending
- 2020-04-17 CN CN202080029182.9A patent/CN113747908A/en active Pending
- 2020-04-17 KR KR1020217036548A patent/KR20220007609A/en unknown
- 2020-04-17 PL PL20722692.9T patent/PL3773648T3/en unknown
- 2020-04-17 MX MX2021012631A patent/MX2021012631A/en unknown
- 2020-04-17 EP EP20722692.9A patent/EP3773648B1/en active Active
- 2020-04-17 CA CA3136978A patent/CA3136978A1/en active Pending
- 2020-04-17 WO PCT/SE2020/050397 patent/WO2020214083A1/en unknown
- 2020-04-17 BR BR112021019663A patent/BR112021019663A2/en unknown
- 2020-04-17 AU AU2020258788A patent/AU2020258788B2/en active Active
-
2021
- 2021-09-29 CL CL2021002527A patent/CL2021002527A1/en unknown
- 2021-10-13 IL IL287226A patent/IL287226A/en unknown
- 2021-11-17 EC ECSENADI202182738A patent/ECSP21082738A/en unknown
-
2023
- 2023-11-16 US US18/510,979 patent/US20240082325A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL287226A (en) | 2021-12-01 |
| BR112021019663A2 (en) | 2021-12-07 |
| AU2020258788B2 (en) | 2024-07-04 |
| US20210154245A1 (en) | 2021-05-27 |
| CN113747908A (en) | 2021-12-03 |
| CA3136978A1 (en) | 2020-10-22 |
| PL3773648T3 (en) | 2024-08-26 |
| WO2020214083A1 (en) | 2020-10-22 |
| EP3773648A1 (en) | 2021-02-17 |
| MX2021012631A (en) | 2021-11-12 |
| ECSP21082738A (en) | 2022-01-31 |
| EP4410298A2 (en) | 2024-08-07 |
| EP3773648C0 (en) | 2024-06-19 |
| CL2021002527A1 (en) | 2022-04-22 |
| AU2020258788A1 (en) | 2021-10-28 |
| US20240082325A1 (en) | 2024-03-14 |
| JP7556881B2 (en) | 2024-09-26 |
| KR20220007609A (en) | 2022-01-18 |
| EP3773648B1 (en) | 2024-06-19 |
| US11857582B2 (en) | 2024-01-02 |
| JP2022529456A (en) | 2022-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287226A (en) | Therapeutic microvesicles of probiotic bacteria | |
| IL271085A (en) | Bacteria for the treatment of disorders | |
| HRP20190580T1 (en) | Combination therapy for treatment of resistant bacterial infections | |
| ZA201805634B (en) | Conjugate of therapeutic enzymes | |
| SG10201913043TA (en) | Novel lactic acid bacteria and use thereof | |
| IL254457B (en) | Combination of bactericidal agent with a lysosomotropic alkalinizing agent for the treatment of a bacterial infection | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| EP3715449C0 (en) | Novel lactic acid bacteria and use thereof | |
| IL281775A (en) | Methods of treatment of infections using bacteria | |
| NO20200776A1 (en) | Probiotic bacteria for fish | |
| IL280343A (en) | Treatment of mucopolysaccharidosis iva | |
| IL290915A (en) | Treatment of bacterial vaginosis | |
| HK1248756A1 (en) | Lactic acid bacteria and their use for the treatment of mastitis | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| IL271236A (en) | Licofligozin for the treatment of non-alcoholic steatohepatitis | |
| GB2615478B (en) | Therapeutic and prophylactic use of microorganisms | |
| GB201614415D0 (en) | Enzymes for the treatment of human enterometabolic dysfunction | |
| EP3122867A4 (en) | Preparation of small colony variants of therapeutic bacteria | |
| IL289338A (en) | Therapeutic interactions of leucomethylthioninium | |
| EP4188403A4 (en) | Treatment of bacterial vaginosis | |
| GB201812861D0 (en) | Methods of administering therapy | |
| IL281969A (en) | New medical use of oxalate-reducing bacteria | |
| IL290548A (en) | Bacteria and methods of use thereof | |
| ZA202003088B (en) | Treatment of tuberculosis | |
| IL274770A (en) | Anti-hutnfr1 therapy of nonalcoholic steatohepatitis |